Lumen Hopes FiberNet Will Capture Attention Of Potential Acquirers
This article was originally published in The Gray Sheet
Executive SummaryLumen Biomedical is counting on the adaptable material and three-dimensional design of its early-stage FiberNet embolic protection device to capture the attention of potential purchasers
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.